How Growth Concealed Vicplas International’s Massive Loss In FY2025

Vicplas International Ltd achieved overall revenue growth, primarily driven by the medical devices segment, although it reported a consolidated loss after tax. The medical devices segment is focused on expanding its global footprint, notably with a new manufacturing facility starting commercial production to enhance manufacturing flexibility. The pipes and pipe fittings segment continues to benefit from robust activity in Singapore’s built environment but faces intensified competition and cost pressures.

 

• Discover how global expansion and the start of commercial production at a crucial new facility in North America is attracting fresh projects and customers

 

• The medical devices segment experienced a significant uplift in orders following major post-pandemic inventory adjustments made by certain customers

 

• Learn about the pipes segment’s move to diversify its portfolio, introducing new uPVC door products which are currently in the initial stages of market commercialisation